Association of FOXE1 polyalanine repeat region with papillary thyroid cancer

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 9, 2012, Pages

  Bullock, Martyn ^a   Duncan, Emma L ^b,c   O'Neill, Christine ^d   Tacon, Lyndal ^a,d   Sywak, Mark ^d   Sidhu, Stan ^a,d   Delbridge, Leigh ^d   Learoyd, Diana ^d   Robinson, Bruce G ^a,d   Ludgate, Marian ^e   Clifton Bligh, Roderick J ^a,d  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; FORKHEAD FACTOR E1; GENOMIC DNA; POLYALANINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA BINDING; FOLLOW UP; FORKHEAD FACTOR E1 GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MAJOR CLINICAL STUDY; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CARCINOMA;

ADULT; AGED; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; COHORT STUDIES; DNA; DNA, COMPLEMENTARY; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GENOTYPE; HEK293 CELLS; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; THYROID NEOPLASMS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84866179877     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-1456     Document Type: Article

References (20)

1. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH 1994 Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1608
2. Pal T, Vogl FD, Chappuis PO, Tsang R, Brierley J, Renard H, Sanders K, Kantemiroff T, Bagha S, Goldgar DE, Narod SA, Foulkes WD 2001 Increased risk for nonmedullary thyroid cancer in the first degree relatives of prevalent cases of nonmedullary thyroid cancer: a hospital-based study. J Clin Endocrinol Metab 86:5307-5312
3. Hemminki K, Eng C, Chen B 2005 Familial risks for nonmedullary thyroid cancer. J Clin Endocrinol Metab 90:5747-5753
4. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464
5. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-induced thyroid carcinoma in Chernobyl. Hum Mol Genet 19:2516-2523
6. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Pérez L, Schiavi F, Leskelä S, Pita G, Milne R, Maravall J, Ramos I, Andía V, Rodríguez-Poyo P, Jara-Albarrán A, Meoro A, del Peso C, Arribas L, Iglesias P, Caballero J, Serrano J, Picó A, Pomares F, Giménez G, López-Mondéjar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodríguez-Antona C, González-Neira A, Matías-Guiu X, Santisteban P, Robledo M 2009 The variant rs186727 in FOXE1 gene confers thyroid cancer susceptibility through recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637
7. Matsuse M, Takahashi M, Mitsutake N, Nishihara E, Hirokawa M, Kawaguchi T, Rogounovitch T, Saenko V, Bychkov A, Suzuki K, Matsuo K, Tajima K, Miyauchi A, Yamada R, Matsuda F, Yamashita S 2011 The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48:645-648
8. Kallel R, Belguith-Maalej S, Akdi A, Mnif M, Charfeddine I, Galofré P, Ghorbel A, Abid M, Marcos R, Ayadi H, Velázquez A, Hadj Kacem H 2010 Genetic Investigation of FOXE1 polyalanine tract in thyroid diseases: new insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomarkers 8:43-51
9. Macchia PE, Mattei MG, Lapi P, Fenzi G, Di Lauro R 1999 Cloning, chromosomal localization and identification of polymorphisms in the human thyroid transcription factor 2 gene (TITF2). Biochimie 81:433-440
10. Brown LY, Brown SA 2004 Alanine tracts: the expanding story of human illness and trinucleotide repeats. Trends Genet 20:51-58
11. O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS 2010 BRAF(V600E)mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancer. Surgery 148:1139-1145; discussion 1145-1146
12. Australo-Anglo-American Spondyloarthritis Consortium (TASC), Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ, Jin R, Zhou X, Bradbury LA, Appleton LH, Davis JC, Diekman L, Doan T, Dowling A, Duan R, Duncan EL, Farrar C, Hadler J, Harvey D, Karaderi T, Mogg R, Pomeroy E, Pryce K, Taylor J, Savage L, Deloukas P, Kumanduri V, Peltonen L, Ring SM, Whittaker P, Glazov E, Thomas GP, Maksymowych WP, Inman RD, Ward MM, Stone MA, Weisman MH, Wordsworth BP, Brown MA 2010 Genome-wide association of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123-127
13. 1000 Genomes Project Consortium 2010 A map of human genome variation from population-scale sequencing. Nature [Erratum (2011) 473:544] 467:1061-1073
14. Clifton-Bligh RJ, Wentworth JM, Heinz P, Crisp MS, John R, Lazarus JH, Ludgate M, Chatterjee VK 1998 Mutation of the gene encoding human TTF-2 associated with thyroid agenesis. Nat Genet 19:399-401
15. Au AY, McBride C, Wilhelm Jr KG, Koenig RJ, Speller B, Cheung L, Messina M, Wentworth J, Tasevski V, Learoyd D, Robinson BG, Clifton-Bligh RJ 2006 PAX8-peroxisome proliferator-activated receptor γ (PPARγ) disrupts normal PAX8 or PPARγ transcriptional function and stimulates follicular thyroid cell growth. Endocrinology 147:367-376
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC 2007 PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 81:559-575
17. Benayoun BA, Caburet S, Dipietromaria A, Bailly-Bechet M, Batista F, Fellous M, Vaiman D, Veitia RA 2008 The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles. Hum Mol Genet 17:3118-3127
18. Carré A, Castanet M, Sura-Trueba S, Szinnai G, Van Vliet G, Trochet D, Amiel J, Léger J, Czernichow P, Scotet V, Polak M 2007 Polymorphic length of FOXE1 alanine stretch: evidence for genetic susceptibility to thyroid dysgenesis. Hum Genet 122:467-476
19. Venza I, Visalli M, Parrillo L, De Felice M, Teti D, Venza M 2011 MSX1 and TGF-β3 are novel target genes functionally regulated by FOXE1. Hum Mol Genet 20:1016-1025
20. Ortiz L, Aza-Blanc P, Zannini M, Cato AC, Santisteban P 1999 The interaction between the Forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. J Biol Chem 274:15213-15221